<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Cadenas-Jimenez I</submitter><funding>Centro de Investigación Biomédica en Red de Enfermedades Infecciosas</funding><funding>Fondo de Investigaciones Sanitarias</funding><funding>Sociedad Española de Neumología y Cirugía Torácica</funding><funding>Centro de Investigación Biomédica en Red de Enfermedades Respiratorias</funding><pagination>87</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12918164</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>27(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Bronchiectasis is a chronic respiratory disease characterized by recurrent exacerbations and persistent inflammation, often associated with bacterial pathogens such as Haemophilus influenzae and Pseudomonas aeruginosa. Phenotypic adaptations (e.g., antimicrobial resistance) complicate treatment and worsen a patient's quality of life.&lt;h4>Methods&lt;/h4>Between 2019 and 2020, we isolated 52 H. influenzae and 48 P. aeruginosa strains from 62 non-CF bronchiectasis patients across three scheduled visits and during exacerbation episodes. Antimicrobial susceptibility (assessed by microdilution) and phenotyping assays (motility and hypermutability) were performed. Whole genome sequencing was applied for analyses of resistance determinants, virulence factors, and genetic diversity.&lt;</pubmed_abstract><journal>Respiratory research</journal><pubmed_title>Epidemiological insights into Haemophilus influenzae and Pseudomonas aeruginosa persistent colonization in non-cystic fibrosis bronchiectasis patients: a longitudinal and multicenter study.</pubmed_title><pmcid>PMC12918164</pmcid><funding_grant_id>698/2018</funding_grant_id><funding_grant_id>CB06/06/1089</funding_grant_id><funding_grant_id>PI22/00257</funding_grant_id><funding_grant_id>CB21/13/00009</funding_grant_id><funding_grant_id>CB06/06/0037</funding_grant_id><pubmed_authors>Rodriguez L</pubmed_authors><pubmed_authors>Oliver A</pubmed_authors><pubmed_authors>Santos S</pubmed_authors><pubmed_authors>Millares L</pubmed_authors><pubmed_authors>Vendrell M</pubmed_authors><pubmed_authors>Simon M</pubmed_authors><pubmed_authors>Ardanuy C</pubmed_authors><pubmed_authors>Dominguez MA</pubmed_authors><pubmed_authors>Benaali-Bakkar Y</pubmed_authors><pubmed_authors>Casabella A</pubmed_authors><pubmed_authors>Calvo-Silveria S</pubmed_authors><pubmed_authors>Monton C</pubmed_authors><pubmed_authors>Goncalves-Carvalho F</pubmed_authors><pubmed_authors>Munoz G</pubmed_authors><pubmed_authors>Saiz-Escobedo L</pubmed_authors><pubmed_authors>Quero S</pubmed_authors><pubmed_authors>Antuori A</pubmed_authors><pubmed_authors>Arque E</pubmed_authors><pubmed_authors>Cadenas-Jimenez I</pubmed_authors><pubmed_authors>Camps-Massa P</pubmed_authors><pubmed_authors>Gonzalez-Diaz A</pubmed_authors><pubmed_authors>Navarro A</pubmed_authors><pubmed_authors>Lacoma A</pubmed_authors><pubmed_authors>Bronchiomics group</pubmed_authors><pubmed_authors>Marti S</pubmed_authors><pubmed_authors>Suarez-Cuartin G</pubmed_authors><pubmed_authors>Barreiro E</pubmed_authors><pubmed_authors>Polverino E</pubmed_authors><pubmed_authors>Calero C</pubmed_authors><pubmed_authors>Plasencia V</pubmed_authors><pubmed_authors>Llunell A</pubmed_authors><pubmed_authors>Garcia-Olive I</pubmed_authors><pubmed_authors>Prat-Aymerich C</pubmed_authors><pubmed_authors>Marin A</pubmed_authors><pubmed_authors>Cuchi E</pubmed_authors><pubmed_authors>Tubau F</pubmed_authors><pubmed_authors>Pomares J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Epidemiological insights into Haemophilus influenzae and Pseudomonas aeruginosa persistent colonization in non-cystic fibrosis bronchiectasis patients: a longitudinal and multicenter study.</name><description>&lt;h4>Background&lt;/h4>Bronchiectasis is a chronic respiratory disease characterized by recurrent exacerbations and persistent inflammation, often associated with bacterial pathogens such as Haemophilus influenzae and Pseudomonas aeruginosa. Phenotypic adaptations (e.g., antimicrobial resistance) complicate treatment and worsen a patient's quality of life.&lt;h4>Methods&lt;/h4>Between 2019 and 2020, we isolated 52 H. influenzae and 48 P. aeruginosa strains from 62 non-CF bronchiectasis patients across three scheduled visits and during exacerbation episodes. Antimicrobial susceptibility (assessed by microdilution) and phenotyping assays (motility and hypermutability) were performed. Whole genome sequencing was applied for analyses of resistance determinants, virulence factors, and genetic diversity.&lt;</description><dates><release>2026-01-01T00:00:00Z</release><publication>2026 Feb</publication><modification>2026-07-09T11:25:12.054Z</modification><creation>2026-07-09T10:48:12.851Z</creation></dates><accession>S-EPMC12918164</accession><cross_references><pubmed>41699695</pubmed><doi>10.1186/s12931-026-03553-1</doi></cross_references></HashMap>